Genetic determinants of cardiovascular remodeling in Uzbek patients with essential hypertension

Terapevticheskii Arkhiv

Volumn 81, Issue 1, 2009, Pages 64-69

  Eliseeva, M R ^a   Srozhidinova, N Z ^a   Khamidullaeva, G A ^a   Abdullaeva, G Zh ^a  

^a NONE

Author keywords

A1166C polymorphism of ATIR gene; Cardiovascular remodeling; Essential hypertension; I D polymorphism of ACE gene; M235T polymorphism of ANG gene; Polymorphism of CYP11B2 gene

Indexed keywords

ARTICLE; BRACHIAL ARTERY; CAROTID ARTERY; ECHOCARDIOGRAPHY; ECHOGRAPHY; GENETIC MARKER; GENETIC POLYMORPHISM; GENETICS; HEART LEFT VENTRICLE HYPERTROPHY; HEART VENTRICLE; HEART VENTRICLE REMODELING; HEMODYNAMICS; HUMAN; HYPERTENSION; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; UZBEKISTAN; VASCULAR ENDOTHELIUM;

BRACHIAL ARTERY; CAROTID ARTERIES; ECHOCARDIOGRAPHY; ENDOTHELIUM, VASCULAR; GENETIC MARKERS; HEART VENTRICLES; HEMODYNAMICS; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RENIN-ANGIOTENSIN SYSTEM; UZBEKISTAN; VENTRICULAR REMODELING;

EID: 63149180359     PISSN: 00403660     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Russian source
2. O'Shaughnessy K. M. The genetics of essential hypertension. Br. J. Clin. Pharmacol. 2001; 51(1): 5-11.
3. Russian source
4. Russian source
5. Lee Y. A., Lindpaintner K. Role of the cardiac renin-angiotensin system in hypertensive cardiac hypertrophy. Eur. Heart J. 1993; 14 (suppl. J): 42-48.
6. Devereux R. B., Reichek N. Echocardiography determination of left ventricular mass in man; anatomic validation of the method. Circulation 1977; 55: 613-618.
7. Teiccholtz L. E., Kruelen T., Herman M. V., Gorlin R. Problems in echocardiography volume determination. Am. J. Cardiol. 1976;37:7-11.
8. Russian source
9. Kupari M., Hautanen A., Lankinen L. et al. Association between human aldosterone synthase (CYP 11B2) gene polymorphisms and left ventricular size, mass, and function. Circulation 1998; 97: 569-575.
10. Russian source
11. Russian source
12. Russian source
13. Russian source
14. Bonnardeaux A., Davies E., Jeimemaitre X. et al. Angiotensin II type 1 receptor gene polymorphisms in human essential hypertension Hypertension 1994; 24: 63-69.
15. Brand E., Chatelain N., Mulatero P. et al. Structural analysis and evaluation of the aldosterone synthase gene in hypertension. Hypertension 1998; 32: 198-204.
16. O'Donnell C. J., Lindpainther K., Larson M. G. et al. The ACE deletion insertion polymorphism and hypertension: on association analysis in the Framingham Heart Study. In: College cardiology, 46-th Annual scientific session 1997; 724-732.
17. Iwai N., Ohmichi N., Nakamura Y. et al. DD genotype of the angiotensin-converting enzyme gene is a risk factor for left ventricular hypertrophy. Circulation 1994; 90: 2622-2628.
18. Russian source
19. Klmura M., Yokota M., Fujimura T. et al Association of a deletion polymorphism of the angiotensin-converting enzyme gene with left ventricular hypertrophy in Japanese women with essential hypertension; multicenter study of 1,919 subjects. Cardiology 1997; 88: 309-314.
20. Ueno H., Tokata M., Yasumoto K. et al. Angiotensin-converting enzyme gene polymorphism and geometric patterns of hypertensive left ventricular hypertrophy. Jpn Heart J. 1999; 40: 589-598.
21. Jeunemaitre X., Soubrier F., Kotelevtsev Y. V. et al. Molecular basis of human hypertension: role of angiotensinogen. Cell 1992; 71(1): 169-180.
22. Kuznetsova T., Staessen J. A., Thijs L. et al. Left ventricular mass in delation to genetic variation in angiotensin II receptors, renin system genes, and sodium excretion. Circulation 2004; 110;2644-2650.
23. Rasmussen L. J., North K. E., Gu C. Ch. et al. A population association study of angiotensinogen polymorphisms and haplotypes with left ventricular phenotypes. Hypertension 2005;46: 1294-1299.
24. Castellano M., Muisan M. L., Beschi M. et al. Angiotensin II type 1 receptor A/C 1166 polymorphism. Relationship with blood pressure and cardiovascular structure. Hypertension 1996; 28: 1076-1080.
25. Kikuya M., Sugimoto K., Katsuya T. et al. A/C 1166 gene polymorphism of the angiotensin II type 1 receptor (ATI) and ambulatory blood pressure: the Ohasama Study. Hypertens. Res. 2003; 26(2): 141-145.
26. Takami S., Katsuya T., Rakugi H. Angiotensin II type 1 receptor gene polymorphism is associated with increased of left ventricular mass but not with hypertension. Am. J. Hypertens. 1998; 11(pt 1): 316-321.
27. Davies E., Holloway C. D., Ingram M. C. et al. Aldosterone excretion rate and blood pressure in essential hypertension are related to polymorphic differences in the aldosterone synthase gene CYP11B2. Hypertension 1999; 33: 703-707.
28. Tiago A. D., Badenhorst D., Nkeh B. et al. Impact of renin-angiotensin-aldosterone system gene variants on the severity of hypertension in patients with newly diagnosed hypertension. Am. J. Hypertens. 2003; 16: 1006-1010.
29. Tamaki S., Iwai N., Tsujita Y., Kinoshita M. Genetic polymorphism of CYP11B2 gene and hypertension in Japanese. Hypertension 1999; 33(pt 2): 266-270.
30. Stella P., Bigatti G., Tizzoni L. et al. Association between aldosterone synthase (CYP11B2) polymorphism and left ventricular mass in human essential hypertension. J. Am. Coll. Cardiol. 2004; 43(2): 265-270.
31. Kupari M., Hautanen A., Lankinen L. et al. Association between human aldosterone synthase (CYP11B2) gene polymorphisms and left ventricular size, mass, and function. Circulation 1998; 97: 569-575.
32. Van Geel P. P., Pinto Y. M., Voors A. A. et al. Angiotensin II type 1 receptor A1166C gene polymorphism is associated with an increased response to angiotensin II in human arteries. Hypertension 2000; 35: 717-721.
33. Russian source